SCHEMBL12824519

SCHEMBL12824519

CC(=O)Nc1n[nH]c2ccc(NC(=O)C(CCN)c3ccc(Cl)c(Cl)c3)cc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 3/20 0.64
▸ CDK2 P24941 3/20 0.64
▸ MAPK1 P28482 3/20 0.64
▸ PLK4 O00444 2/20 0.64
▸ MAPK13 O15264 2/20 0.64
▸ DAPK3 O43293 2/20 0.64
▸ PRKCG P05129 2/20 0.64
▸ CDK1 P06493 2/20 0.64
▸ RPS6KB1 P23443 2/20 0.64
▸ CLK2 P49760 2/20 0.64
▸ GSK3B P49841 2/20 0.64
▸ LIMK1 P53667 2/20 0.64
▸ MAPK12 P53778 2/20 0.64
▸ CDK5 Q00535 2/20 0.64
▸ PKN2 Q16513 2/20 0.64
▸ HIPK4 Q8NE63 2/20 0.64
▸ AURKB Q96GD4 2/20 0.64
▸ CLK4 Q9HAZ1 2/20 0.64
▸ CSNK1G1 Q9HCP0 2/20 0.64
▸ STK17A Q9UEE5 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12825312 0.88 CDK2 (0.60) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12824983 0.88 ROCK2 (0.69) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12824757 0.86 MAPK1 (0.65) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12825386 0.86 CDK2 (0.60) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12824984 0.86 ROCK2 (0.67) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12825861 0.85 ROCK2 (0.57) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12824527 0.84 MAPK1 (0.58) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12825860 0.84 ROCK2 (0.57) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12826062 0.83 AURKB (0.64) DYRK1ACDK2MAPK1PLK4MAPK13
SCHEMBL12825525 0.83 GSK3B (0.56) DYRK1ACDK2MAPK1PLK4MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295412-A1 Indazole compounds useful as protein kinase inhibitors Vertex Pharmaceuticals Incorporated (US) 2011-03-16 — — EP disclosed
Send feedback